Bedinvetmab

$780

Only 1000 item(s) left in stock.

Products Details

Product Description

– Bedinvetmab (ZTS-00508841) is a canine monoclonal antibody (mAb) targeting nerve growth factor (NGF). Bedinvetmab inhibits NGF interaction with tropomyosin receptor kinase A (trkA) and p75 neurotrophin receptor (p75NTR) receptors. Bedinvetmab can be used for the research of osteoarthritis pain in dogs[1][2].

Web ID

– HY-P99297

Storage Temperature

– Store at -80°C for 2 years

Shipping

– Dry Ice

Applications

– COVID-19-immunoregulation

Molecular Formula

– N/A

References

– [1]Corral MJ, et, al. A prospective, randomized, blinded, placebo-controlled multisite clinical study of bedinvetmab, a canine monoclonal antibody targeting nerve growth factor, in dogs with osteoarthritis. Vet Anaesth Analg. 2021 Nov;48(6):943-955.|[2]Krautmann M, et, al. Laboratory safety evaluation of bedinvetmab, a canine anti-nerve growth factor monoclonal antibody, in dogs. Vet J. 2021 Oct;276:105733.

CAS Number

– 2171034-69-6

Molecular Weight

– N/A

Compound Purity

– 99.80

SMILES

– [Bedinvetmab]

Clinical Information

– No Development Reported

Research Area

– Inflammation/Immunology

Solubility

– H2O

Target

– Trk Receptor

Pathway

– Neuronal Signaling;Protein Tyrosine Kinase/RTK

Product type

– Inhibitory Antibodies

Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.

My Cart
Close Wishlist
Close Recently Viewed
Categories

Please fill out this form to request the file. We will send it to your Email address shortly. Thanks.

Please enable JavaScript in your browser to complete this form.

=

Please fill out this form to request the pricing.
We will send it to your email address shortly.
Thanks.

Please enable JavaScript in your browser to complete this form.

=